87 related articles for article (PubMed ID: 12930326)
21. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
22. CD40 ligand in CLL pathogenesis and therapy.
Schattner EJ
Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
[TBL] [Abstract][Full Text] [Related]
23. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia.
Thompson AA; Do HN; Saxon A; Wall R
Leuk Lymphoma; 1999 Feb; 32(5-6):561-9. PubMed ID: 10048429
[TBL] [Abstract][Full Text] [Related]
24. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
25. CD40 ligand, Bcl-2 and apoptosis in B-chronic lymphocytic leukemia.
Hussein OA; Omran AA; Elnaggar AM; Fathy A
Egypt J Immunol; 2009; 16(2):27-36. PubMed ID: 22059351
[TBL] [Abstract][Full Text] [Related]
26. Relationship between chronic lymphocytic leukemia and small lymphocytic lymphoma. A comparative study of membrane phenotypes in 270 cases.
Batata A; Shen B
Cancer; 1992 Aug; 70(3):625-32. PubMed ID: 1623477
[TBL] [Abstract][Full Text] [Related]
27. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
[TBL] [Abstract][Full Text] [Related]
28. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells.
Ohshima K; Tutiya T; Yamaguchi T; Suzuki K; Suzumiya J; Kawasaki C; Haraoka S; Kikuchi M
Int J Cancer; 2002 Apr; 98(4):567-72. PubMed ID: 11920617
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
[TBL] [Abstract][Full Text] [Related]
30. The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
Giannopoulos K; Mertens D; Bühler A; Barth TF; Idler I; Möller P; Kröber A; Greiner J; Chocholska S; Dmoszyñska A; Roliñski J; Döhner H; Stilgenbauer S; Schmitt M
Leukemia; 2009 Mar; 23(3):519-27. PubMed ID: 19092852
[TBL] [Abstract][Full Text] [Related]
31. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S; Goddard RV; Kaminski ER; Prentice AG
Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
[TBL] [Abstract][Full Text] [Related]
32. Association of CD4+/CD56+/CD57+/CD8+(dim) large granular lymphocytic leukemia, splenic B-cell lymphoma with circulating villous lymphocytes, and idiopathic erythrocytosis.
Lima M; Gonçalves C; Marques L; Martin MC; Teixeira MA; Queirós ML; Santos AH; Balanzategui A; Garcia-Sanz R; Pinto-Ribeiro AC; Justiça B; Orfão A
Ann Hematol; 2001 Nov; 80(11):685-90. PubMed ID: 11757730
[TBL] [Abstract][Full Text] [Related]
33. B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors.
Schroers R; Pukrop T; Dürig J; Haase D; Dührsen U; Trümper L; Griesinger F
Leuk Lymphoma; 2004 Aug; 45(8):1677-81. PubMed ID: 15370224
[TBL] [Abstract][Full Text] [Related]
34. Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Boyer DF; Lindeman NI; Harris NL; Ferry JA
Am J Surg Pathol; 2014 Feb; 38(2):279-88. PubMed ID: 24418862
[TBL] [Abstract][Full Text] [Related]
35. CD3+ CD8+ CD56- clonal large granular lymphocyte leukaemia and HIV infection.
Pulik M; Lionnet F; Genet P; Petitdidier C; Jary L; Fourcade C
Br J Haematol; 1997 Aug; 98(2):444-5. PubMed ID: 9266947
[TBL] [Abstract][Full Text] [Related]
36. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation.
Ghia P; Chiorazzi N; Stamatopoulos K
J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of cytotoxic T-cell activation, chemokine receptors, and adhesion molecules in blood and serum in patients with oral lichen planus.
Pekiner FN; Demirel GY; Borahan MO; Ozbayrak S
J Oral Pathol Med; 2012 Jul; 41(6):484-9. PubMed ID: 22404248
[TBL] [Abstract][Full Text] [Related]
38. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia.
Rezvany MR; Jeddi-Tehrani M; Rabbani H; Lewin N; Avila-Cariño J; Osterborg A; Wigzell H; Mellstedt H
Br J Haematol; 2000 Nov; 111(2):608-17. PubMed ID: 11122109
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.
Scrivener S; Kaminski ER; Demaine A; Prentice AG
Br J Haematol; 2001 Mar; 112(4):959-64. PubMed ID: 11298591
[TBL] [Abstract][Full Text] [Related]
40. Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells.
Li LH; Biagi E; Allen C; Shivakumar R; Weiss JM; Feller S; Yvon E; Fratantoni JC; Liu LN
Cancer Gene Ther; 2006 Feb; 13(2):215-24. PubMed ID: 16082377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
